Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giaccone

Showing results (281-290 of 359) with videos related to

Pageof 36
Sort By:
The Journal of Pathology|November 1, 1995
Differential expression of the c-kit proto-oncogene in germ cell tumoursM A Izquierdo, P Van der Valk, J Van Ark-Otte, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development GroupG Giaccone, E F Smit, M de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenaseC H Smorenburg, G J Peters, C J van Groeningen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2015
Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumorsM G Kris, D R Camidge, G Giaccone, et al.
Clinical & Developmental Immunology|March 6, 2008
Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptorH van Cruijsen, K Hoekman, A G M Stam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: single-centre experience in 145 patientsJ M van Riel, C J van Groeningen, S H Albers, et al.
International Journal of Cancer|June 11, 1996
MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungsG Giaccone, J van Ark-Otte, G J Rubio, et al.
Seminars in Oncology|August 1, 1995
Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancerG Giaccone, M Huizing, P E Postmus, et al.
The American Journal of Pathology|November 1, 1992
Multidrug resistance gene (P-glycoprotein) expression in the human fetusC K van Kalken, G Giaccone, P van der Valk, et al.
British Journal of Cancer|March 10, 2005
Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11D Oosterhoff, R M Overmeer, M de Graaf, et al.
Pageof 36

Showing results (281-290 of 359) with videos related to

Sort By:
Pageof 36
The Journal of Pathology|November 1, 1995
Differential expression of the c-kit proto-oncogene in germ cell tumoursM A Izquierdo, P Van der Valk, J Van Ark-Otte, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development GroupG Giaccone, E F Smit, M de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenaseC H Smorenburg, G J Peters, C J van Groeningen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2015
Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumorsM G Kris, D R Camidge, G Giaccone, et al.
Clinical & Developmental Immunology|March 6, 2008
Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptorH van Cruijsen, K Hoekman, A G M Stam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: single-centre experience in 145 patientsJ M van Riel, C J van Groeningen, S H Albers, et al.
International Journal of Cancer|June 11, 1996
MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungsG Giaccone, J van Ark-Otte, G J Rubio, et al.
Seminars in Oncology|August 1, 1995
Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancerG Giaccone, M Huizing, P E Postmus, et al.
The American Journal of Pathology|November 1, 1992
Multidrug resistance gene (P-glycoprotein) expression in the human fetusC K van Kalken, G Giaccone, P van der Valk, et al.
British Journal of Cancer|March 10, 2005
Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11D Oosterhoff, R M Overmeer, M de Graaf, et al.
Pageof 36